Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Giant basal cell carcinoma. Improvement and vitiligo-like hypopigmentation after intermittent treatment with 5% imiquimod.

Urbina F.

Acta Dermatovenerol Croat. 2012;20(4):275-8. No abstract available.

PMID:
23317492
2.

Imiquimod-induced vitiligo after treatment of nodular basal cell carcinoma.

Gowda S, Tillman DK, Fitzpatrick JE, Gaspari AA, Goldenberg G.

J Cutan Pathol. 2009 Aug;36(8):878-81. doi: 10.1111/j.1600-0560.2008.01134.x.

PMID:
19586497
3.

Vitiligo-like depigmentation induced by imiquimod treatment of superficial basal cell carcinoma.

Sriprakash K, Godbolt A.

Australas J Dermatol. 2009 Aug;50(3):211-3. doi: 10.1111/j.1440-0960.2009.00541.x. Review.

PMID:
19659986
4.

Treatment of multiple basal cell carcinomas in the scalp with imiquimod 5% cream.

Hannuksela-Svahn A, Nordal E, Christensen OB.

Acta Derm Venereol. 2000 Sep-Oct;80(5):381-2. No abstract available.

PMID:
11200841
5.

Vitiligo-like hypopigmentation with poliosis following treatment of superficial basal cell carcinoma with imiquimod.

Jacob SE, Blyumin M.

Dermatol Surg. 2008 Jun;34(6):844-5. doi: 10.1111/j.1524-4725.2008.34158.x. Epub 2008 Mar 24. No abstract available.

PMID:
18363730
6.

Imiquimod-induced depigmentation: report of two cases and review of the literature.

Burnett CT, Kouba DJ.

Dermatol Surg. 2012 Nov;38(11):1872-5. doi: 10.1111/j.1524-4725.2012.02512.x. Epub 2012 Jul 17. Review. No abstract available.

PMID:
22805097
7.

Residual basal cell carcinoma after treatment with imiquimod: a caution on assuming complete cure.

Harting M, Vujevich J, Goldberg LH.

Dermatol Surg. 2007 Dec;33(12):1516-9. No abstract available.

PMID:
18076623
8.

Possible mechanisms in the induction of vitiligo-like hypopigmentation by topical imiquimod.

Mashiah J, Brenner S.

Clin Exp Dermatol. 2008 Jan;33(1):74-6. Epub 2007 Nov 2.

PMID:
17979992
9.

Complete basal cell carcinoma remission with imiquimod in a patient with nevoid basal cell carcinoma syndrome and associated basal cell carcinoma of the scalp and invasive ductal breast cancer.

Quist SR, Franke I, Helmdach M, Kraus C, Reis A, Froster UG, Fehsecke D, Gollnick HP, Bonnekoh B.

J Am Acad Dermatol. 2011 Mar;64(3):611-3. doi: 10.1016/j.jaad.2009.07.046. No abstract available.

PMID:
21315966
10.

Multiple basal cell carcinomas after radiation treatment: successful treatment with topical imiquimod.

Santiago Sánchez-Mateos D, Goiriz Valdés R, Daudén Tello E.

Clin Exp Dermatol. 2010 Mar;35(2):199-200. doi: 10.1111/j.1365-2230.2009.03325.x. Epub 2009 May 26. No abstract available.

PMID:
19486047
11.

Re: "Imiquimod 5% cream for the treatment of periocular basal cell carcinoma".

Pakdel F, Kashkouli MB.

Ophthal Plast Reconstr Surg. 2011 Jul-Aug;27(4):305; author reply 305-6. doi: 10.1097/IOP.0b013e3181f8a9e3. No abstract available.

PMID:
20966793
12.

[Topical treatment of melanoma skin metastases with imiquimod].

Sigüenza M, Pizarro A, Mayor M, Vidaurrázaga C, Miralles L, González-Beato M, Casado M.

Actas Dermosifiliogr. 2005 Mar;96(2):111-5. Review. Spanish.

PMID:
16476347
13.

Imiquimod 5% cream for the treatment of periocular Basal cell carcinoma.

Carneiro RC, de Macedo EM, Matayoshi S.

Ophthal Plast Reconstr Surg. 2010 Mar-Apr;26(2):100-2. doi: 10.1097/IOP.0b013e3181b8dd71.

PMID:
20305508
14.
15.

Treatment of infiltrating basal cell carcinoma with the combination of intralesional IFNalpha-2b and topical imiquimod 5% cream.

Turan A, Saricaoglu H, Baskan EB, Toker SC, Tunali S.

Int J Dermatol. 2009 Feb;48(2):214-5. doi: 10.1111/j.1365-4632.2009.03576.x. No abstract available.

PMID:
19200213
16.

Topical application of imiquimod for the treatment of high-risk facial basal cell carcinoma in Gorlin syndrome.

Vereecken P, Monsieur E, Petein M, Heenen M.

J Dermatolog Treat. 2004 Apr;15(2):120-1. No abstract available.

PMID:
15204165
17.

Fifty-five basal cell carcinomas treated with topical imiquimod: outcome at 5-year follow-up.

Vidal D, Matías-Guiu X, Alomar A.

Arch Dermatol. 2007 Feb;143(2):266-8. No abstract available.

PMID:
17310012
18.

Efficacy and safety of 5% imiquimod cream in treating patients with multiple superficial basal cell carcinomas.

Marks R, Owens M, Walters SA; Australian Multi-Centre Trial Group.

Arch Dermatol. 2004 Oct;140(10):1284-5. No abstract available.

PMID:
15492200
19.

5% imiquimod cream for the treatment of large superficial basal cell carcinoma.

Shumack S, Gebauer K, Quirk C, Macdonald K, Walters SA, Owens M.

Arch Dermatol. 2004 Oct;140(10):1286-7. No abstract available.

PMID:
15492202
20.

Has imiquimod 5% cream a role in the management of recurrent basal cell carcinoma?

RUIZ-VILLAVERDE R, SANCHEZ-CANO D, BURKHARDT-PEREZ P, SINTES RN.

Eur J Dermatol. 2009 Sep-Oct;19(5):481-3. doi: 10.1684/ejd.2009.0741. Epub 2009 Jun 15.

PMID:
19527989
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk